Solifenacin Succinate (solifenacin succiate) NDC 35561-285

NDC codes

FDA NDC Directory

Product NDC (as listed)35561-285Labeler and product segments. Claims need a package NDC.

Product NDC at billing width35561-0285Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
35561-285-00	35561028500	256410 TABLET, FILM COATED in 1 BOX (35561-285-00)Marketed from May 20, 2019
35561-285-10	35561028510	30 TABLET, FILM COATED in 1 BOTTLE (35561-285-10)Marketed from May 20, 2019
35561-285-11	35561028511	90 TABLET, FILM COATED in 1 BOTTLE (35561-285-11)Marketed from May 20, 2019
35561-285-13	35561028513	500 TABLET, FILM COATED in 1 BOTTLE (35561-285-13)Marketed from May 20, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Solifenacin Succinate
Generic name (nonproprietary): solifenacin succiate
Active ingredients: Solifenacin succinate — 5 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Bostal LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 210281
Marketing start: May 20, 2019
Listing expires: Dec 31, 2027
Other FDA classes: Cholinergic Muscarinic Antagonists (Mechanism)
Identifiers: Product ID 35561-285_49fcc8a4-31aa-6975-e063-6394a90a9389SPL ID 49fcc8a4-31aa-6975-e063-6394a90a9389SPL set ID d155c739-6870-4938-ba91-8c1b4b90afe4RxCUI 477367, 477372UNII KKA5DLD701UPC 0335561286137, 0335561285130
Pharmacologic class: Cholinergic Muscarinic Antagonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N435561028500 followed by a unit qualifier and the quantity

Package 35561-0285-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Feb 4, 2026.

Indications (excerpt from the label)

Solifenacin Succinate Tablets are indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. Solifenacin Succinate Tablets are a muscarinic antagonist indicated for the treatment of adults with overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency.( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 210281

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 210281
Product	Strength	Form · route	Labeler	Product NDC
Solifenacin Succinatesolifenacin succiate	Solifenacin succinate 5 mg/1	Tablet, Film coatedOral	AvKARE	42291-739
Solifenacin Succinate	Solifenacin succinate 10 mg/1	Tablet, Film coatedOral	AvKARE	42291-740
Solifenacin Succinate	Solifenacin succinate 10 mg/1	Tablet, Film coatedOral	Bostal LLC	35561-286